Marking World Cancer Day 2026, the Gem Cancer Centre at Gem Hospital today launched Dr. GEM, an advanced AI-powered cancer intelligence chatbot designed to enhance patient education and support clinical decision-making, and felicitated cancer warriors on 3rd February 2026, at the hospital auditorium.
The launch of Dr. GEM marks a significant milestone in addressing the growing challenge of cancer-related misinformation by offering accurate, scientifically validated, and reliable information to patients and caregivers, thereby improving treatment understanding and strengthening patient confidence.
The ceremony was graced by eminent dignitaries, including Sivathanu Pillai, a renowned Indian scientist from ISRO and widely known as the Father of BrahMos, and Saravana Sundar, Inspector General of Police, West Zone, Coimbatore.
Speaking at the launch, Dr. Praveen Raj, Chief Executive Officer, GEM Cancer Centre, said, In today’s era, misinformation about cancer poses a significant challenge for patients. Dr. GEM has been developed to provide accurate, evidence-based information precisely when patients need it most.
This platform will enhance patient confidence and treatment understanding, empowering individuals to make informed decisions about their care.
Highlighting the evolving role of technology in oncology, Dr. Palanivelu, Chairman, GEM Hospital Group, remarked, “Cancer care today extends far beyond hospital walls.
Real transformation happens when technology, humanity, and awareness converge. Initiatives like Dr.GEM represent an essential component of the future of cancer care, ensuring patients have access to trustworthy information alongside expert medical treatment. This reflects our commitment to comprehensive and compassionate oncology.
The event also honoured cancer warriors for their resilience and courage, reinforcing GEM Cancer Centre’s patient-centric approach and commitment to integrating innovation with compassionate care.
With the successful launch of Dr.GEM, GEM Cancer Centre reaffirmed its dedication to leveraging artificial intelligence to enhance patient engagement, improve access to reliable information, and set new benchmarks in technology- enabled oncology care.
